Table 2. Univariate analysis of selected baseline variables.
Hazard Ratio (95% CI) | P Value | |
---|---|---|
Male gender | 1.292 (0.501–3.334) | 0.596 |
Age (years) | 1.045 (1.011–1.079) | 0.008 |
NYHA functional class | ||
II | 0.468 (0.052–4.187) | 0.497 |
III | 0.903 (0.109–7.499) | 0.924 |
IV | 1.554 (0.187–12.919) | 0.683 |
Hemodynamics | ||
mPAP (mmHg) | 0.995 (0.957–1.033) | 0.779 |
CO (L/min) | 0.393 (0.195–0.794) | 0.009 |
PVR (WU) | 1.053 (0.959–1.155) | 0.280 |
BNP (pg/dL) | 1.001 (1.000–1.003) | 0.026 |
6MWD (m) | 0.997 (0.992–1.003) | 0.377 |
Pre-PTE targeted therapy | 0.640 (0.210–1.943) | 0.431 |